| 1 |
WORLD HEALTH ORGANIZATION. Influenza (seasonal)[EB/OL]. (2025-02-28) [2025-07-28].
|
| 2 |
WILDEN J J, JACOB J C, EHRHARDT C, et al. Altered signal transduction in the immune response to influenza virus and S. pneumoniae or S. aureus co-infections[J]. International journal of molecular sciences, 2021, 22(11): 5486.
|
| 3 |
MIKUŠOVÁ M, TOMČÍKOVÁ K, BRIESTENSKÁ K, et al. The contribution of viral proteins to the synergy of influenza and bacterial co-infection[J]. Viruses, 2022, 14(5): 1064.
|
| 4 |
林立, 於梦菲. 流感病毒和细菌共感染研究进展[J]. 中国实用儿科杂志, 2018, 33(9): 721-725.
|
| 5 |
JOSEPH C, TOGAWA Y, SHINDO N. Bacterial and viral infections associated with influenza[J]. Influenza and other respiratory viruses, 2013, 7 Suppl 2(Suppl 2): 105-113.
|
| 6 |
史庆丰, 姜晨彦, 蒋露芳. 流感病毒致继发性肺部细菌感染的易感机制研究进展[J]. 上海预防医学, 2016, 28(11): 813-817.
|
| 7 |
RICH H E, MCCOURT C C, ZHENG W Q, et al. Interferon lambda inhibits bacterial uptake during influenza superinfection[J]. Infection and immunity, 2019, 87(5): e00114-19.
|
| 8 |
MORRIS D E, CLEARY D W, CLARKE S C. Secondary bacterial infections associated with influenza pandemics[J]. Frontiers in microbiology, 2017, 8: 1041.
|
| 9 |
JINJARAK Y, NOY I, TA Q. Pandemics and economic growth: Evidence from the 1968 H3N2 influenza[J]. Economics of disasters and climate change, 2022, 6(1): 73-93.
|
| 10 |
WORLD BANK GROUP. Global economic prospects, june 2025[EB/OL]. (2025-06-10)[2025-08-27].
|
| 11 |
SEKI M, KOSAI K, YANAGIHARA K, et al. Disease severity in patients with simultaneous influenza and bacterial pneumonia[J]. Internal medicine, 2007, 46(13): 953-958.
|
| 12 |
MORENS D M, TAUBENBERGER J K, FAUCI A S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness[J]. The journal of infectious diseases, 2008, 198(7): 962-970.
|
| 13 |
CHIEN Y W, KLUGMAN K P, MORENS D M. Bacterial pathogens and death during the 1918 influenza pandemic[J]. The New England journal of medicine, 2009, 361(26): 2582-2583.
|
| 14 |
VIBOUD C, SIMONSEN L, FUENTES R, et al. Global mortality impact of the 1957-1959 influenza pandemic[J]. Journal of infectious diseases, 2016, 213(5): 738-745.
|
| 15 |
ROBERTSON L, CALEY J P, MOORE J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A[J]. Lancet, 1958, 2(7040): 233-236.
|
| 16 |
HERS J F, MASUREL N, MULDER J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza[J]. Lancet, 1958, 2(7057): 1141-1143.
|
| 17 |
SCHWARZMANN S W, ADLER J L, SULLIVAN R J J R, et al. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969[J]. Archives of internal medicine, 1971, 127(6): 1037-1041.
|
| 18 |
KALLEN A J, BRUNKARD J, MOORE Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season[J]. Annals of emergency medicine, 2009, 53(3): 358-365.
|
| 19 |
SMITH G J, VIJAYKRISHNA D, BAHL J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic[J]. Nature, 2009, 459(7250): 1122-1125.
|
| 20 |
LEE E H, WU C, LEE E U, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city[J]. Clinical infectious diseases: An official publication of the infectious diseases society of America, 2010, 50(11): 1498-1504.
|
| 21 |
CENTERS FOR DISEASE CONTROL AND PREVENTION(CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A(H1N1)-United States, May-August 2009[J]. Morbidity and mortality weekly report, 2009, 58(38): 1071-1074.
|
| 22 |
LUCAS S. Predictive clinicopathological features derived from systematic autopsy examination of patients who died with A/H1N1 influenza infection in the UK 2009-10 pandemic[J]. Health technology assessment, 2010, 14(55): 83-114.
|
| 23 |
PALACIOS G, HORNIG M, CISTERNA D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza[J]. PLoS one, 2009, 4(12): e8540.
|
| 24 |
MARTÍN-LOECHES I, SANCHEZ-CORRAL A, DIAZ E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus[J]. Chest, 2011, 139(3): 555-562.
|
| 25 |
KIM H S, KIM J H, SHIN S Y, et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea[J]. Journal of Korean medical science, 2011, 26(1): 22-27.
|
| 26 |
METERSKY M L, MASTERTON R G, LODE H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza[J]. International journal of infectious diseases, 2012, 16(5): e321-e331.
|
| 27 |
KLOMP M, GHOSH S, MOHAMMED S, et al. From virus to inflammation, how influenza promotes lung damage[J]. Journal of leukocyte biology, 2021, 110(1): 115-122.
|
| 28 |
OLIVA J, TERRIER O. Viral and bacterial co-infections in the lungs: Dangerous liaisons[J]. Viruses, 2021, 13(9): 1725.
|
| 29 |
PITTET L A, HALL-STOODLEY L, RUTKOWSKI M R, et al. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae[J]. American journal of respiratory cell and molecular biology, 2010, 42(4): 450-460.
|
| 30 |
ROWE H M, MELIOPOULOS V A, IVERSON A, et al. Direct interactions with influenza promote bacterial adherence during respiratory infections[J]. Nature microbiology, 2019, 4(8): 1328-1336.
|
| 31 |
AMPOMAH P B, LIM L H K. Influenza A virus-induced apoptosis and virus propagation[J]. Apoptosis, 2020, 25(1-2): 1-11.
|
| 32 |
SHIZUKUISHI S, OGAWA M, KURODA E, et al. Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption[J]. Cell rep, 2024, 43(3): 113962.
|
| 33 |
LIU L, GAO T, LIU J, et al. Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis[J]. International immunopharmacology, 2026, 172: 116191.
|
| 34 |
KALIL A C, THOMAS P G. Influenza virus-related critical illness: Pathophysiology and epidemiology[J]. Critical care, 2019, 23(1): 258.
|
| 35 |
DIDIERLAURENT A, GOULDING J, PATEL S, et al. Sustained desensitization to bacterial toll-like receptor ligands after resolution of respiratory influenza infection[J]. The journal of experimental medicine, 2008, 205(2): 323-329.
|
| 36 |
MALOSH R E, MARTIN E T, HEIKKINEN T, et al. Efficacy and safety of oseltamivir in children: Systematic review and individual patient data meta-analysis of randomized controlled trials[J]. Clinical infectious diseases, 2018, 66(10): 1492-1500.
|
| 37 |
BOHANNON C D, ENDE Z, CAO W, et al. Influenza virus infects and depletes activated adaptive immune responders[J]. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, 8(16): e2100693.
|
| 38 |
GHONEIM H E, THOMAS P G, MCCULLERS J A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections[J]. Journal of immunology, 2013, 191(3): 1250-1259.
|
| 39 |
BARMAN T K, METZGER D W. Disease tolerance during viral-bacterial co-infections[J]. Viruses, 2021,13(12): 2362.
|
| 40 |
SMALL C L, SHALER C R, MCCORMICK S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung[J]. Journal of immunology, 2010, 184(4): 2048-2056.
|
| 41 |
JIA L, XIE J, ZHAO J, et al. Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection[J]. Frontiers in cellular and infection microbiology, 2017, 7: 338.
|
| 42 |
MCCULLERS J A. The co-pathogenesis of influenza viruses with bacteria in the lung[J]. Nature reviews. Microbiology, 2014, 12(4): 252-262.
|
| 43 |
SENCIO V, BARTHELEMY A, TAVARES L P, et al. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production[J]. Cell reports, 2020, 30(9): 2934-2947.
|
| 44 |
MCNAMEE L A, HARMSEN A G. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection[J]. Infection and immunity, 2006, 74(12): 6707-6721.
|
| 45 |
ELLIS G T, DAVIDSON S, CROTTA S, et al. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection[J]. EMBO reports, 2015, 16(9): 1203-1218.
|
| 46 |
ISHIKAWA H, FUKUI T, INO S, et al. Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung[J]. Virology, 2016, 499: 23-29.
|
| 47 |
LODOEN M B, LANIER L L. Natural killer cells as an initial defense against pathogens[J]. Current opinion in immunology, 2006, 18(4): 391-398.
|
| 48 |
SCOTT M J, HOTH J J, STAGNER M K, et al. CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent[J]. Clinical and experimental immunology, 2004, 137(3): 469-477.
|
| 49 |
ZHANG X, YANG Y, CHEN S, et al. Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infection[J]. Mucosal immunology, 2023, 16(2): 153-166.
|
| 50 |
CHEN T, LIU J, YU R, et al. Targeting TLR7 reprograms macrophage function to attenuate influenza-associated Staphylococcus aureus coinfection[J]. Microbial pathogenesis, 2026, 210: 108208.
|
| 51 |
ROBINSON K M, KOLLS J K, ALCORN J F. The immunology of influenza virus-associated bacterial pneumonia[J]. Current opinion in immunology, 2015, 34: 59-67.
|
| 52 |
GU Y, ZUO X, ZHANG S, et al. The mechanism behind influenza virus cytokine storm[J]. Viruses, 2021, 13(7): 1362.
|
| 53 |
HASSAN A, BLANCHARD N. Microbial (co)infections: Powerful immune influencers[J]. PLoS pathogens, 2022, 18(2): e1010212.
|
| 54 |
ALSHAMMARI A K, MAINA M, BLANCHARD A M, et al. Understanding the molecular interactions between influenza a virus and streptococcus proteins in co-infection: A scoping review[J]. Pathogens, 2025, 14(2): 114.
|
| 55 |
KING S J, HIPPE K R, WEISER J N. Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae[J]. Molecular microbiology, 2006, 59(3): 961-974.
|
| 56 |
WADOWSKY R M, MIETZNER S M, SKONER D P, et al. Effect of experimental influenza a virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects[J]. Infection and immunity, 1995, 63(4): 1153-1157.
|
| 57 |
CHONMAITREE T, REVAI K, GRADY J J, et al. Viral upper respiratory tract infection and otitis media complication in young children[J]. Clinical infectious diseases: An official publication of the infectious diseases society of America, 2008, 46(6): 815-823.
|
| 58 |
HEIKKINEN T, CHONMAITREE T. Importance of respiratory viruses in acute otitis media[J]. Clinical microbiology reviews, 2003, 16(2): 230-241.
|
| 59 |
LANGOUËT-ASTRIÉ C, OSHIMA K, MCMURTRY S A, et al. The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial pneumonia[J]. Cell reports, 2022, 41(9): 111721.
|
| 60 |
XING A, NG H M, JIAO H, et al. The prevalence, epidemiological, and molecular characterization of Methicillin-resistant Staphylococcus aureus (MRSA) in Macau (2017—2022) [J]. Microorganisms, 2024, 12(1): 148.
|
| 61 |
SOULTAN K M, KEWALRAMANI A, BRADBURY A, et al. Clinical impact of influenza a coinfection on Staphylococcus aureus pneumonia during the 2024—2025 influenza season in New York City[J]. International journal of infectious diseases, 2025, 160: 108072.
|